Abstract
Pulmonary hypertension due to chronic thromboembolic disease is potentially curable with pulmonary thromboendarterectomy surgery. As a result, it is important for clinicians to recognize and appropriately diagnose this form of pulmonary hypertension. Advances in this field with changes in surgical technique, the availability of PH-targeted medical therapy for select patient subgroups, and the development of balloon pulmonary angioplasty have broadened therapeutic options for patients. This review will examine what is known about the epidemiology and medical conditions placing patients at risk of developing this disease, will present an approach to evaluation of patients with suspected chronic thromboembolic disease, and will describe the surgical and non-surgical management of this unique patient population.
Similar content being viewed by others
References
Daily PO, Auger WR (1999) Historical perspective: surgery for chronic thromboembolic disease. Sem Thorac Cardiovasc Surg 11(2):143–151
Pepke-Zaba J, Hoeper MM, Humbert M (2013) Chronic thromboembolic pulmonary hypertension: advances from bench to patient management. Eur Resp J 41:8–9
Simonneau G, Gatzoulis MA, Adatia I et al (2013) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62:D34–D41
Pepke-Zaba J, Delcroix M, Lang I et al (2011) Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 124:1973–1981
Pengo V, Lensing ASA, Prins MH, Marchiori A, Davidson BL, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, Prandoni P (2004) Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 350:2257–2264
Miniati M, Monti S, Bottai M, Scoscia E, Bauleo C, Tonelli L, Dainelli A, Giuntini C (2006) Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism. Medicine 85:253–262
Becattini C, Agnelli G, Pesavento R, Silingardi M, Poggio R, Taliani MR, Ageno W (2006) Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest 130:172–175
Dentali F, Donadini M, Gianni M, Bertolini A, Squizzato A, Venco A, Ageno W (2009) Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism. Thromb Res 124:256–258
Klok FA, van Kralingen KW, van Dijk APJ, Heyning FH, Vliegen HW (2010) Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acutepulmonary embolism. Haematologica 95:970–975
Korkmaz A, Ozlu T, Ozsu S, Kazaz Z, Bulbul Y (2012) Long-term outcomes in acute pulmonary thromboembolism: the incidence of chronic thromboembolic pulmonary hypertension and associated risk factors. Clin Appl Thromb Hemost 18:281–288
Guerin L, Couturaud F, Parent F et al (2014) Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Thromb Haemost 112:598–605
Bonderman D, Turecek PL, Jakowitsch J, Weltermann A, Adlbrecht C, Schneider B, Kneussl M, Rubun LJ, Kyrle PA, Klepetko W, Maurer G, Lang IM (2003) High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost 90:372–376
Wong CL, Szydio R, Gibbs S, Laffan M (2010) Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension. Blood Coagul Fibrinolysis 21:201–206
Bonderman D, Wilkens H, Wakounig S, Schafers H-J, Jansa P, Linder J, Simkova I, Martischnig AM, Dudczak J, Sadushi R, Skoro-Sajer N, Klepetko W, Lang IM (2009) Risk factors for chronic thromboembolic pulmonary hypertension. Eur Resp J 33:325–331
O’Donnell J, Laffan MA (2001) The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus Med 11:343–351
Homoncik M, Gessl A, Ferlitsch A, Jilma B, Vierhapper H (2007) Altered platelet plug formation in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab 92:3006–3012
Lang IM, Pesavento R, Bonderman D, Yuan JX-J (2013) Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Resp J 41:462–468
Quarck R, Wynants M, Verbeken E, Meyns B, Delcroix M (2015) Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension. Eur Resp J 46:431–443
Bernard J, Yi ES (2007) Pulmonary thromboendarterectomy: a clinicopathologic study of 200 consecutive pulmonary thromboendarterectomy cases in one institution. Hum Pathol 38:871–877
Wynants M, Quarck R, Ronisz A, Alfaro-Moreno E, Van Raemdonck D, Meyns B, Delcroix M (2012) Effects of C-reactive protein on human pulmonary vascular cells in chronic thromboembolic pulmonary hypertension. Eur Resp J 40:886–894
Morris TA, Marsh JJ, Chiles PG, Magana MM, Liang NC, Soler X, Desantis DJ, Ngo D, Woods VL Jr (2009) High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. Blood 114:1929–1936
Zabini D, Nagaraj C, Stacher E, Lang IM, Nierlich P, Klepetko W, Heinemann A, Olschewski H, Balint Z, Olschewski A (2012) Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunction. PLoS One 7(8):e43793
Sakao S, Hao H, Tanabe N, Kasahara Y, Kurosu K, Tatsumi K (2011) Endothelial-like cells in chronic thromboembolic pulmonary hypertension: crosstalk with myofibroblast-like cells. Resp Res 12:109
Firth AL, Yao W, Ogawa A, Madani MM, Lin GY, Yuan JX (2010) Multipotent mesenchymal progenitor cells are present in endarterectomized tissues from patients with chronic thromboembolic pulmonary hypertension. Am J Physiol Cell Physiol 298:C1217–C1225
Moser KM, Bloor CM (1993) Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest 103:685–692
Dorfmūller P, Gūnther S, Ghigna M-R, de Montpréville BoulateD, Paul J-F, Jaïs X, Decante B, Simonneau G, Darteville P, Humbert M, Fadel E, Mercier O (2014) Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature. Eur Resp J 44(5):1275–1288
McCann C, Gopalan D, Sheares K, Screaton N (2012) Imaging in pulmonary hypertension, part 2: large vessel diseases. Postgrad Med J 88:317–325
Morris TA, Auger WR, Ysrael MZ, Olson LK, Channick RN, Fedullo PF, Moser KM (1996) Parenchymal scarring is associated with restrictive spirometric defects in patients with chronic thromboembolic pulmonary hypertension. Chest 110:399–403
Steenhuis LH, Groen HJM, Koeter GH, van der Mark TW (2000) Diffusion capacity and haemodynamics in primary and chronic thromboembolic pulmonary hypertension. Eur Respir J 16:276–281
Kapitan KS, Buchbinder M, Wagner PD, Moser KM (1989) Mechanisms of hypoxemia in chronic thromboembolic pulmonary hypertension. Am Rev Respir Dis 139:1149–1154
Held M, Grün M, Kaiser R, Wilkens H, Jany BH (2014) Cardiopulmonary exercise testing to detect pulmonary hypertension in patients with suspected chronic thromboembolic pulmonary hypertension and normal echocardiography. Respiration 87:379–387
Held M, Hesse A, Gött F et al (2014) A symptom-related monitoring program following pulmonary embolism for the early detection of CTEPH: a prospective observational registry study. Pulm Med 14:141–148
Raisinghani A, Ben-Yehuda O (2006) Echocardiography in chronic thromboembolic pulmonary hypertension. Semin Thorac Cardiovasc Surg 18:230–235
Blanchard DG, Malouf PJ, Gurudevan SV et al (2009) Utility of right ventricular Tei index in the noninvasive evaluation of chronic thromboembolicpulmonary hypertension before and after pulmonary thromboendarterectomy. JACC Cardiovasc Imaging 2(2):143–149
Xie Y, Burke BM, Kopelnik A et al (2014) Echocardiographic estimation of pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension: utility of right heart doppler measurements. Echocardiography 31:29–33
Marston N, Brown JP, Olson N et al (2015) Right ventricular strain before and after pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Echocardiography 32:1115–1121
Kim NH, Delcroix M, Jenkins DP, Channick R, Darteville P, Jansa P, Lang I, Madani MM, Ogino H, Pengo V, Mayer E (2013) Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol 62:D92–D99
Tunariu N, Gibbs SJ, Win Z, Gin-Sing W, Graham A, Gishen P, Al-Nahhas A (2007) Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic disease as a treatable cause of pulmonary hypertension. J Nucl Med 48:680–684
He J, Fang W, Lv B, He JG, Xiong CM, Liu ZH, He ZX (2012) Diagnosis of chronic thromboembolic pulmonary hypertension: comparison of ventilation/perfusion scanning and multidetector computed tomography pulmonary angiography with pulmonary angiography. Nucl Med Commun 33(5):459–463
Sugiura T, Tanabe N, Matsuura Y, Shigeta A, Kawata N, Jujo T, Yanagawa N, Sakao S, Kasahara Y, Tatsumi K (2013) Role of 320-slice computed tomography in the diagnostic workup of patients with chronic thromboembolic pulmonary hypertension. Chest 143:1070–1077
Lisbona R, Kreisman H, Novales-Diaz J, Derbekyan V (1985) Perfusion lung scanning: differentiation of primary from thromboembolic pulmonary hypertension. Am J Roentgenol 144:27–30
Powe JE, Palevsky HI, McCarthy KE, Alavi A (1987) Pulmonary arterial hypertension: value of perfusion scintigraphy. Radiology 164:727–730
Ryan KL, Fedullo PF, Davis GB, Vasquez TE, Moser KM (1998) Perfusion scan findings understate the severity of angiographic and hemodynamic compromise in chronic thromboembolic pulmonary hypertension. Chest 93:1180–1185
Kerr KM, Auger WR, Fedullo PF, Channick RN, Yi ES, Moser KM (1995) Large vessel pulmonary arteritis mimicking chronic thromboembolic disease. Am J Respir Crit Care Med 152:367–373
Rossi SE, McAdams HP, Rosado-de-Christenson ML, Franks TJ, Galvin JR (2001) Fibrosing mediastinitis. Radiographics 21:737–757
Kerr KM (2005) Pulmonary artery sarcoma masquerading as chronic thromboembolic pulmonary hypertension. Nat Clin Pract Cardiovasc Med 2:108–112
Auger WR, Fedullo PF, Moser KM, Buchbinder M, Peterson KL (1992) Chronic major- vessel chronic thromboembolic pulmonary artery obstruction: appearance at angiography. Radiology 183:393–398
Wijesuriya S, Chandratreya L, Medford AR (2013) Chronic pulmonary emboli and radiologic mimics on CT pulmonary angiography. A diagnostic challenge. Chest 143:1460–1471
Doǧan H, de Roos A, Geleijins J, Huisman MV, Kroft LJM (2015) The role of computed tomography in the diagnosis of acute and chronic pulmonary embolism. Diagn Interv Radiol 21:307–316
Willemink MJ, van Es HW, Koobs L, Morshuis WJ, Snijder RJ, van Heesewijk JPM (2012) CT evaluation of chronic thromboembolic pulmonary hypertension. Clin Radiol 67:277–285
McKie SJ, Hardwick DJ, Reid JH, Murchison JT (2005) Features of cardiac disease demonstrated on CT angiography. Clin Radiol 60:31–38
Lee NS, Blanchard DG, Knowlton KU, McDivitt AM, Pretorius V, Madani MM, Fedullo PF, Kerr KM, Kim NH, Poch DS, Auger WR, Daniels LB (2015) Prevalence of coronary artery-pulmonary artery collaterals in patients with chronic thromboembolic pulmonary hypertension. Pulm Circ 5(2):313–321
Dournes G, Verdier D, Montaudon M et al (2014) Dual-energy CT perfusion and angiography in chronic thromboembolic pulmonary hypertension: diagnostic accuracy and concordance with radionuclide scintigraphy. Eur Radiol 24:42–51
Meinel FG, Graef A, Thierfelder KM et al (2013) Automated quantification of pulmonary perfused blood volume by dual-energy CTPA in chronic thromboembolic pulmonary hypertension. Rofo 186:151–156
Grgic A, Miodek F, Schäfers H-J et al (2016) Assessment of operability by means of CTPA and perfusion SPECT in patients with chronic thromboembolic pulmonary hypertension. Acta Radiol 57(1):33–40
Ley S, Ley-Zaporozhan J, Pitton MB, Schneider J, Wirth GM, Mayer E, Duber C, Kreitner K-F (2012) Diagnostic performance of state-of-the-art imaging techniques for morphological assessment of vascular abnormalities in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Eur Radiol 22:607–616
Nikolaou K, Schoenberg SO, Attenberger U, Scheidler J, Dietrich O, Kuehn B, Rosa F, Huber A, Leuchte H, Baumgartner R, Behr J, Reiser MF (2005) Pulmonary arterial hypertension: diagnosis with fast perfusion imaging and high-spatial- resolution MR angiography—preliminary experience. Radiology 236:694–703
Rajaram S, Swift AJ, Capener D, Telfer A et al (2013) 3D contrast-enhanced ling perfusion MRI is an effective screening tool for chronic thromboembolic pulmonary hypertension: results from the ASPIRE Registry. Thorax 68:677–678
Rolf A, Rixe J, Kim WK et al (2014) Right ventricular adaptation to pulmonary pressure load in patients with chronic thromboembolic pulmonary hypertension before and after successful pulmonary endarterectomy—a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 16:96
Fukui S, Ogo T, Morita Y et al (2014) Right ventricular reverse remodelling after balloon pulmonary angioplasty. Eur Respir J 43:1394–1402
Kreitner K-F, Ley S, Kauczor H-U, Mayer E, Kramm T, Pitton MB, Krummenauer F, Thelen M (2004) Chronic thromboembolic pulmonary hypertension: pre- and postoperative assessment with breath-hold magnetic resonance techniques. Radiology 32:535–543
Claessen G, La Gerche A, Dymarkowski S et al (2015) Pulmonary vascular and right ventricular reserve in patients with normalized resting hemodynamics after pulmonary endarterectomy. J Am Heart Assoc 4(3):e001601–e001602. doi:10.1161/JAHA.114.001602
Ohno Y, Koyama H, Yoshikawa T et al (2012) Contrast-enhanced multidetector-row computed tomography vs. time-resolved magnetic resonance angiography vs. contrast-enhanced perfusion MRI: assessment of treatment response by patients with inoperable chronic thromboembolic pulmonary hypertension. J Magn Reson Imaging 36:612–623
Ota H, Sugimura K, Miura M, Shimokawa H (2015) Four-dimensional flow magnetic resonance imaging visualizes drastic change in vortex flow in the main pulmonary artery after percutaneous transluminal pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension. Eur Heart J 36(25):1630. doi:10.1093/eurheartj/ehv054
Fenster BE, Browning J, Schroeder JD et al (2015) Vorticity is a marker of right ventricular diastolic dysfunction. Am J Physiol Heart Circ Physiol. doi:10.1152/ajpheart.00278.2015
Madani MM, Auger WR, Pretorius V, Sakakibara N, Kerr KM, Kim NK, Fedullo PF, Jamieson SW (2012) Pulmonary endarterectomy: recent changes in a single institution’s experience of more than 2700 patients. Ann Thorac Surg 94:97–103
Mayer E, Jenkins D, Lindner J, D’Armini A, Kloek J, Meyns B, Ilkjaer LB, Klepetko W, Delcroix M, Lang I, Pepke-Zaba J, Simonneau G, Darteville P (2011) Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg 141:702–710
de Perrot M, Thenganatt J, McRae K, Moric J, Mercier O, Pierre A, Mak S, Granton J (2015) Pulmonary endarterectomy in severe chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant 34:369–375
Taboada D, Pepke-Zaba J, Jenkins DP, Berman M, Treacy CM, Cannon JE, Toshner M, Dunning JJ, Ng C, Tsui SS, Sheares KK (2014) Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease. Eur Resp J 44(6):1635–1645
van der Plas MN, Reesink HJ, Roos CM (2010) Pulmonary endarterectomy improves dyspnea by the relief of dead space ventilation. Ann Thorac Surg 89:347–352
Berman M, Hardman G, Sharples L, Pepke-Zaba J, Sheares K, Tsui S, Dunning J, Jenkins DP (2012) Pulmonary endarterectomy: outcomes in patients aged >70. Eur J Cardio-Thorac Surg 41:e154–e160
Fernandes TM, Auger WR, Fedullo PF, Kim NH, Poch DS, Madani MM, Pretorius VG, Jamieson SW, Kerr KM (2014) Baseline body mass index does not significantly affect outcomes after pulmonary thromboendarterectomy. Ann Thorac Surg 98:1776–1781
Madani MM, Jamieson SW (2006) Technical advances of pulmonary endarterectomy for chronic thromboembolic disease. Semin Cardiovasc Thorac Surg 18:243–249
Freed DH, Thomson BM, Berman M, Tsui SSL, Dunning J, Sheares KK, Pepke-Zaba J, Jenkins DP (2011) Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension. J Thorac Cardiovasc Surg 141:383–387
Saouti N, Morshuis WJ, Heijmen RH, Snijder RJ (2009) Long-term outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a single institution experience. Eur J Cardiothorac Surg 35:947–952. doi:10.1016/j.ejcts.2009.01.023 (discussion 952)
Rahnavardi M, Yan TD, Cao C, Vallely MP, Bannon PG, Wilson MK (2011) Pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension: a systematic review. Ann Thorac Cardiovasc Surg 17:435–445
Condliffe R, Kiely DG, Gibbs JS, Corris PA, Peacock AJ, Jenkins DP, Hodgkins D, Goldsmith K, Hughes RJ, Sheares K, Tsui SSL, Armstrong IJ, Torpy C, Crackett R, Carlin CM, Das C, Coghlan JG, Pepke-Zaba J (2008) Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 177:1122–1127
Corsico AG, D’Armini AM, Cerveri I, Klersy C, Ansaldo E, Niniano R, Gatto E, Monterosso C, Morsolini M, Nicolardi S, Tramontin C, Pozzi E, Vigano M (2008) Long term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med 178:419–424
D’Armini AM, Morsolini M, Mattiucci G, Grazioli V, Pin M, Valentini A, Silvaggio G, Klersy C, Dore R (2014) Pulmonary endarterectomy for distal chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg 148(3):1005–1011
Bonderman D, Skoro-Sajer N, Jakowitsch J, Adlbrecht C, Dunkler D, Taghavi S, Klepetko W, Kneussl M, Lang IM (2007) Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation 115:2153–2158
Thistlethwaite PA, Kemp A, Du L, Madani MM, Jamieson SW (2006) Outcomes of pulmonary thromboendarterectomy for treatment of extreme thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg 131:307–313
Bresser P, Pepke-Zaba J, Jaïs X, Humbert M, Hoeper MM (2006) Medical therapies for chronic thromboembolic pulmonary hypertension. An evolving paradigm. Proc Am Thorac Soc 3:594–600
Ghofrani HA, D’Armini AM, Grimminger F, Hoeper MM, Kim NH, Mayer E, Simonneau G, Wilkins MR, Fritsch A, Neuser D, Weimann G, Wang C (2013) Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med 369:319–329
Simonneau G, D’Armini AM, Ghofrani H-A, Grimminger F, Hoeper MM, Jansa P, Kim NH, Wang C, Wilkins M, Fritsch A, Davie N, Colorado P, Mayer E (2015) Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: along-term extension study (CHEST-2). Eur Respir J 45:1293–1302
Jais X, D’Armini A, Jansa P, Torbicki A, Delcroix M, Ghofrani HA, Hoeper MM, Lang IM, Mayer E, Pepke-Zapa J, Perchenet L, Morganti A, Simonneau G, Rubin LJ (2008) Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol 52:2127–2134
Suntharalingam J, Treacy CM, Doughty NJ, Goldsmith K, Soon E, Toshner MR, Sheares KK, Hughes R, Morrell NW, Pepke-Zaba J (2008) Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension. Chest 134:229–236
Cabrol S, Souza R, Jais X, Fadel E, Ali RHS, Humbert M, Darteville P, Simonneau G, Sitbon O (2007) Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant 26:357–362
Krug S, Hammerschmidt S, Pankau H, Wirtz H, Seyfarth HJ (2008) Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension. Respiration 76:154–159
Skoro-Sajer N, Bonderman D, Wiesbauer F, Harja E, Jakowitsch J, Klepetko W, Kneussl MP, Lang IM (2007) Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension. J Thromb Haemost 5:483–489
Jensen KW, Kerr KM, Fedullo PF, Kim NH, Test VJ, Ben-Yehuda O, Auger WR (2009) Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. Circulation 120:1248–1254
Voorburg JAI, Cats VM, Buis B, Bruschke AVG (1988) Balloon angioplasty in the treatment of pulmonary hypertension caused by pulmonary embolism. Chest 94:1249–1253
Feinstein JA, Goldhaber SZ, Lock JE, Ferndandes SM, Landzberg MJ (2001) Balloon angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation 103:10–13
Mizoguchi H, Ogawa A, Munemasa M, Mikouchi H, Ito H, Matsubara H (2012) Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 5:748–755
Katoaka M, Inami T, Hayashida K, Shimura N, Ishiguro H, Abe T, Tamura Y, Ando M, Fukuda K, Yoshino H, Satoh T (2012) Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 5:756–762
Sugimura K, Fukumoto Y, Satoh K, Nochioka K, Miura Y, Aoki T, Tatebe S, Miyamichi-Yamamoto S, Shimokawa H (2012) Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J 76:485–488
Andreassen AK, Ragnarsson A, Gude E, Geiran O, Andersen R (2013) Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Heart 99:1415–1420
Inami T, Kataoka M, Shimura N, Ishiguro H, Yanagisawa R, Taguchi H, Fukuda K, Yoshino H, Satoh T (2013) Pulmonary edema predictive scoring index (PEPSI), a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty. JACC Cardiovasc Interv 7:725–736
Taniguchi Y, Miyagawa K, Nakayama K, Kinutani H, Shinke T, Okada K, Okita Y, Hirata KI, Emoto N (2014) Ballon pulmonary angioplasty: an additional treatment option to improve the prognosis of patients with chronic thromboembolic pulmonary hypertension. Eurointervention 10:518–525
Shimura N, Kataoka M, Inami T, Yanagisawa R, Ishiguro H, Kawakami T, Higuchi Y, Ando M, Fukuda K, Yoshino H, Satoh T (2015) Additional percutaneous transluminal pulmonary angioplasty for residual or recurrent pulmonary hypertension after pulmonary endarterectomy. Int J Cardiol 183:138–142
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. David Poch has served as a speaker on behalf of Bayer Pharmaceuticals.
Additional information
Drs. David S. Poch and William R. Auger have contributed equally to this article.
Rights and permissions
About this article
Cite this article
Poch, D.S., Auger, W.R. Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes. Heart Fail Rev 21, 309–322 (2016). https://doi.org/10.1007/s10741-015-9518-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10741-015-9518-3